Xvivo Perfusion AB (publ) (STO: XVIVO)

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had revenue of 198.48M SEK in the quarter ending September 30, 2024, with 35.38% growth. This brings the company's revenue in the last twelve months to 750.59M, up 30.92% year-over-year. In the year 2023, Xvivo Perfusion AB had annual revenue of 597.54M with 43.88% growth.

• Revenue (ttm): 750.59M
• Revenue Growth: +30.92%
• P/S Ratio: 18.71
• Revenue / Employee: 4.66M
• Employees: 160
• Market Cap: 14.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%
Dec 31, 2020	179.86M	-40.98M	-18.55%
Dec 31, 2019	220.84M	32.97M	17.55%